Michael Schomaker and colleagues estimate the mortality associated with starting ART at different CD4 thresholds among children aged 2-5 years using observational data collected in cohort studies in Southern Africa. Please see later in the article for the Editors' Summary
Reference:
Schomaker, M., Egger, M., Ndirangu, J., Phiri, S., Moultrie, H., Technau, K., ... & Davies, M. A. (2013). When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLoS medicine, 10(11), e1001555. doi:10.1371/journal.pmed.1001555
Schomaker, M., Egger, M., Ndirangu, J., Phiri, S., Moultrie, H., Technau, K., ... Wood, R. (2013). When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLOS Medicince, http://hdl.handle.net/11427/15006
Schomaker, Michael, Matthias Egger, James Ndirangu, Sam Phiri, Harry Moultrie, Karl Technau, Vivian Cox, Janet Giddy, Cleophas Chimbetete, and Robin Wood "When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa." PLOS Medicince (2013) http://hdl.handle.net/11427/15006
Schomaker M, Egger M, Ndirangu J, Phiri S, Moultrie H, Technau K, et al. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLOS Medicince. 2013; http://hdl.handle.net/11427/15006.
Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.